Impact of Vaginal Estrogen on the Urobiome in Postmenopausal Women With Recurrent Urinary Tract Infection
- PMID: 33978602
- DOI: 10.1097/SPV.0000000000001051
Impact of Vaginal Estrogen on the Urobiome in Postmenopausal Women With Recurrent Urinary Tract Infection
Abstract
Objective: The aim of this study was to describe effects of vaginal estrogen (VE) on the urogenital microbiome in postmenopausal women with recurrent urinary tract infections (rUTIs).
Methods: This is a secondary analysis of 17 participants enrolled in a randomized controlled trial of VE versus placebo on urinary tract infection recurrence in postmenopausal women with rUTIs. Paired clean-catch urine samples were collected at baseline and after 6 months of VE and sequenced using 16S rRNA gene sequencing. Sequence reads were analyzed using Quantitative Insights Into Microbial Ecology 2. Changes in α diversity, β diversity, and differentially abundant genera were measured between paired baseline and 6-month samples and between those with a urinary tract infection at 6 months (failures) and those without (successes).
Results: Of the 17 women, 11 were successes and 6 were failures after 6 months of VE treatment. There was a significant change in α diversity from baseline to month 6 in samples overall (Kruskal-Wallis χ2 = 3.47, P = 0.037) and in the treatment success group (Yuen T = -2.53, P = 0.035). The increase in relative abundance of Lactobacillus crispatus, Lactobacillus gasseri, and Lactobacillus iners AB-1 was correlated with month 6. A relative bloom of L. crispatus compared with L. gasseri was associated with treatment success (Kruskal-Wallis χ2 = 4.9, P = 0.0014).
Conclusions: Lactobacillus increases in the urogenital microbiome of postmenopausal women with rUTI after 6 months of VE. However, only the relative increase in L. crispatus specifically may be associated with treatment success.
Copyright © 2021 American Urogynecologic Society. All rights reserved.
Conflict of interest statement
K.F. received grant/research support from Valencia Technologies. E.S.L. is a consultant in Axonics and received grant/research support from Boston Scientific, Cogentix/Uroplasty, and Pfizer, and UpToDate Royalties. The remaining others have declared they have no conflicts of interest.
References
-
- Foxman B. Urinary tract infection syndromes. Infect Dis Clin North Am 2014;28(1):1–13. doi:10.1016/j.idc.2013.09.003. - DOI
-
- Laupland KB, Ross T, Pitout JD, et al. Community-onset urinary tract infections: a population-based assessment. Infection 2007;35(3):150–153. doi:10.1007/s15010-007-6180-2. - DOI
-
- Bermingham SL, Ashe JF. Systematic review of the impact of urinary tract infections on health-related quality of life. BJU Int 2012;110(11c):E830–E836. doi:10.1111/j.1464-410X.2012.11337.x. - DOI
-
- Raz R, Gennesin Y, Wasser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000;30(1):152–156. doi:10.1086/313596. - DOI
-
- Romano JM, Kaye D. UTI in the elderly: common yet atypical. Geriatrics 1981;36(6):113–115, 120. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7227817. Accessed July 10, 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
